Mark R. Willig

Specialty Laboratories, Inc. provides clinical reference laboratory services. It focuses on cutting-edge research and development of existing diagnostic tests to produce assays. The company was founded in 1975 and is located in Valencia, CA.

CardioDx, Inc. operates as a cardiovascular genomic diagnostics firm. It develops proprietary tests that improve treatment decisions and patient outcomes on coronary artery disease, cardiac arrhythmia, and heart failure. The company was founded by David L. Levison and Christopher R. Burrow in 2004 and is headquartered in Redwood, CA.

Myriad Genetic Laboratories, Inc. provides cancer predisposition testing services. It operates as a biopharmaceutical company that focuses on developing therapeutic and predictive medicine products. The company was founded on October 11, 1995 and is headquartered in Salt Lake City, UT.

Abbott Diagnostics, Inc. develops, manufactures and sells medical diagnostic instrument, test and automation products. The company is headquartered in Santa Clara, CA.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Key Proteo Inc specializes in novel peptide screening for newborn babies and is specialized in multiplex analysis for extremely low abundance proteins from a few drops of blood (DBS). The company is located in the US. The American company's mission is to provide preemptive treatment for genetic diseases before they are clinically manifested by expanding and improving newborn screening programs.